Korean J Dermatol.  2010 Aug;48(8):684-688.

Blastoid Mantle Cell Lymphoma: A Case Report

Affiliations
  • 1Department of Dermatology, College of Medicine, Soonchunhyang Universiy, Cheonan, Korea. dermsung@schmc.ac.kr
  • 2Department of Pathology, College of Medicine, Soonchunhyang Universiy, Cheonan, Korea.

Abstract

Mantle cell lymphoma (MCL) is a low-grade malignant lymphoma derived from a subset of B-cells localized in the mantle zone of the lymphoid follicle. MCL commonly involves extranodal sites, usually as a manifestation of disseminated disease. The immunophenotype of MCL is characterized as CD20+, CD5+ and Cyclin D1+. Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course. In the blastoid variant, the genetic profile is often more complex and includes tetraploid chromosomes, CCND1 amplification, a higher incidence of p53 gene mutations, and p16(INK4a) deletions. We report a case of a 62-year-old male patient who presented with erythematous subcutaneous nodules on the lower back. He had been treated for BV-MCL of the testis which had occurred 1 year ago. The analysis of histopathological and immunohistochemical examinations of the skin lesions also revealed a BV-MCL.

Keyword

Blastoid; Mantle cell lymphoma; Skin

MeSH Terms

B-Lymphocytes
Cyclin-Dependent Kinase Inhibitor p16
Cyclins
Genes, p53
Humans
Incidence
Lymphoma
Lymphoma, Mantle-Cell
Male
Middle Aged
Skin
Testis
Tetraploidy
Cyclin-Dependent Kinase Inhibitor p16
Cyclins
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr